NSC |
Compound |
Enrichment |
Correlation |
NSC 726144 |
Waol A FD-211 |
0.0385067071027343 |
0.14305438 |
NSC 732830 |
N1-(4-fluorophenyl)-4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihyd ro-1H-3-pyrrolylamino)benzamide |
0.0385067071027343 |
0.17225701 |
NSC 733752 |
Null |
0.0385067071027343 |
-0.01406583 |
NSC 734307 |
3,4-Dihydroxy-N(3-O-methyl-estra-1,3,5(10)-trien-ol-17b-yl)c innamide |
0.0385067071027343 |
0.1965481 |
NSC 747252 |
Trihexyl(tetradecyl)Phosphonium Hexafluorophosphate |
0.0385067071027343 |
-0.14223816 |
NSC 751393 |
2-(4,5-dibenzoyl-1,3-dithiol-2-ylidene)-1-ethyl-6-(phenylimino)-3-thioxo-2,3-dihydro-1H-thieno[2,3-b][1,4]thiazin-7(6H)-one |
0.0385067071027343 |
0.20699377 |
NSC 752464 |
methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate |
0.0385067071027343 |
0.13964829 |
NSC 107124 |
Camptothecin Derivative |
0.0385067071027345 |
0.4907936 |
NSC 128687 |
6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) |
0.0385067071027345 |
0.52189637 |
NSC 264880 |
Dihydro-5-azacytidine |
0.0385067071027345 |
0.23827226 |